Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

The project created a standardized system for classifying skin lesions in lab rats and mice.

GRHL3 is important for controlling gene activity in skin cells during different stages of their development.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

People with androgenetic alopecia may have a higher risk of heart problems compared to those with alopecia areata or healthy individuals.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Oxidative stress is linked to mild patchy alopecia areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

New research is helping develop better treatments for alopecia areata.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.